ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, Z.-L.
Right arrow Articles by Zeng, Y.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, Z.-L.
Right arrow Articles by Zeng, Y.-M.
Annals of Clinical & Laboratory Science 37:349-355 (2007)
© 2007 Association of Clinical Scientists

Effects of Intrathecal Injection of Prednisolone Acetate on Expression of NR2B Subunit and nNOS in Spinal Cord of Rats after Chronic Compression of Dorsal Root Ganglia

Zheng-Liang Ma1, Wei Zhang1, Xiao-Ping Gu1, Wen-Sheng Yang2 and Yin-Ming Zeng2
1 Department of Anesthesiology, Drum Tower Hospital, Nanjing University, Nanjing, China; 2 Jiangsu Institute of Anesthesiology, Xuzhou Medical College, Xuzhou, China

Address correspondence to Dr Zheng-Liang Ma, Department of Anesthesiology, Drum Tower Hospital, Medical Dept. of Nanjing University, Nanjing 210008, Jiangsu Province, China; tel 86 25 8330 4616; fax 86 25 8331 7016; e-mail mazhengliang1964{at}yahoo.com.cn.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Acknowledgement
 References
 
N-methyl-D-aspartate receptor subunit 2B (NR2B) and neuronal nitric oxide synthase (nNOS) play important roles in the mechanism of neuropathic pain. To elucidate how glucocorticoids affect this mechanism, we studied the effects of intrathecal (it) injection of prednisolone acetate (PA) on a nociceptive stimulus and the changes of nNOS and NR2B subunit expression in the spinal dorsal horn of Sprague Dawley rats following chronic compression of the dorsal root ganglia (CCD). Paw withdrawal mechanical threshold (PWMT) and paw withdrawal thermal latency (PWTL) were measured for 15 days postoperatively. An it injection of PA (2.0 mg/kg) every 3 days for postoperative days 1 to 15 inhibited the thermal hyperalgesia and tactile allodynia of CCD rats. Chronic compression of the dorsal root ganglia induced time-dependent upregulation of nNOS and NR2B subunits of N-methyl-D-aspartate receptor within the spinal cord dorsal horn ipsilateral to CCD. Both upregulations were significantly diminished by it administration of PA (2.0 mg/kg), but not by lower doses of PA (0.5 or 1.0 mg/kg). The results suggest that PA upregulation of neuronal nitric oxide synthase and NR2B subunit expression in the spinal dorsal horn contributes to PA inhibition of hyperalgesia induced by chronic compression of dorsal root ganglia.

Keywords: spinal dorsal horn, prednisolone, nNOS, NR2B, neuropathic pain, spinal cord compression


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Acknowledgement
 References
 
Chronic pain remains a major health care problem afflicting patients with low back pain and sciatica. Glucocorticoid (GC) injections have been used to treat neuropathic pain for over 40 years. The success of hormonal therapy was partly attributed to GC anti-inflammatory activity [1,2]. In recent years, GC receptors (GR) have been described in various neuronal populations of the spinal cord. In motor neurons of rats, acute GC treatment increases the activity of neurons, decreases neurofilament degradation, restores neuronal energy metabolism, and stimulates axonal regeneration, sprouting and neuronal survival [3]. Less information is available about the effects of GC in sensory areas of the spinal cord, although GR are also present in dorsal horn neurons.

In the present study, we examined the effects of GC in the superficial dorsal horn (laminae I–III) areas, which are involved in the transmission of nociceptive inputs and the control of sympathetic outflow. The mechanisms of neuropathic pain involve changes in afferent and central spinal sensory relays, leading to neuronal hyperexcitability [4]. Central sensitization crucially involves spinal N-methyl-D-aspartate receptors (NMDAR) [5]. NMDAR antagonists have been shown to reverse neuropathic pain behaviors [6] and reduce dorsal horn neuronal hyper-responsiveness [7,8]. A recent study demonstrates that the NR2B subunit plays a key role in this process. Wei Guo et al [9] reported a prolonged increase of NR2B subunit in spinal dorsal horn neurons of rats caused by peripheral inflammation.

Another response to neuronal activation in the sensory spinal cord areas is the expression of nitric oxide synthase (NOS). NOS can be activated by NMDA receptor post-synaptically, and reports indicate that NO-producing neurons maintain and facilitate hyperalgesia. NOS activity is up-regulated in the laminae I–III following peripheral inflammation, axotomy, and spinal cord lesions [10]. Recent data suggest that nNOS may be the most important subgroup of NOS and a close relationship between nNOS and neuropathic pain has been demonstrated by many previous studies. Although there is no information about GC effects on NOS in the spinal cord, data from other systems show that GC down-regulates this enzyme [11]. Thus, it is possible that nNOS constitutes an important target of GC action during neuropathic pain.

The objectives of this investigation were (a) to determine changes in NR2B and nNOS at several time points after chronic compression of the dorsal root ganglion (CCD), and (b) to asses the responses of these parameters to administration of prednisolone acetate (PA), in order to elucidate the anti-nociceptive mechanisms of PA at the spinal level. To our knowledge, the modulation of NR2B and nNOS by GC has not previously been explored in CCD rats.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Acknowledgement
 References
 
Commercial sources of reagents used in this research were as follows: prednisolone acetate, Sigma-Aldrich Co., Shanghai, China; nNOS and NR2B primary antibody, Santa Cruz Biotechnology, Santa Cruz, CA, USA; PBS buffer, ABC kit, and other reagents, Boster Co., Wuhan, China. Sprague-Dawley rats (250 to 300 g, male) were provided by the Experimental Animal Center of Xuzhou Medical College and were kept with a 12 hr/12 hr light-dark cycle. All experiments were approved by the Animal Care and Use Committee of Xuzhou Medical College.

Implantation of intrathecal catheter.  Rats were implanted with catheters by the method of Yaksh and Rudy [12]. In brief, each rats was anesthetized with pentobarbital sodium (30 mg/kg, ip), the occipital muscles were bluntly separated, and the cisternal membrane was exposed. A polyethylene catheter (PE-10) was inserted via an incision in the cisterna magna and advanced 7.3–7.5 cm caudally to the level of the lumbar enlargement. After the rat had recovered from anesthesia, correct intrathecal placement was confirmed by injection of 10 µl of 2% lidocaine through the catheter. The catheter was judged to be intrathecal if paralysis and dragging of bilateral hind limbs occurred within 30 sec after this injection. Rats with signs of motor dysfunction were excluded from the experiment. The rats were housed individually after surgery and allowed to recover 5 days before the CCD test.

Experimental groups.  The rats were assigned to 2 groups: 7 day and 15 day. Each group was sub-divided into 5 sub-groups as follows:

  1. (sham group): rats without CCD + it injection of artificial cerebrospinal fluid (ACSF) (20 µl);
  2. (ACSF group): rats with CCD + it injection of ACSF (20 µl);
  3. (PA 0.5 mg/kg group): rats with CCD + it injection of PA, 0.5 mg/kg;
  4. (PA 1.0 mg/kg group): rats with CCD + it injection of PA, 1.0 mg/kg;
  5. (PA 2.0 mg/kg group): rats with CCD + it injection of PA, 2.0 mg/kg.

The it injections were given every 3 days postoperatively. For the PA injection groups, the catheters were rinsed with 5 µl of ACSF.

Chronic compression of dorsal root ganglia (CCD).  Chronic compression of dorsal root ganglia was performed under anesthesia with pentobarbital sodium (30 mg/kg, ip). The right L4 and L5 intervertebral foramina were exposed and a stainless steel wire (4 mm long, 0.7 mm diameter) was inserted in each to provide stable compression of the L4 and L5 dorsal root ganglion [13]. Sham surgery was performed by exposing the right L4 and L5 intervertebral foramina without compression.

Behavioral studies.  Mechanical allodynia was assessed by use of von Frey filaments (Stoelting Co., Wood Dale, IL, USA). Rats were placed in individual plastic boxes (20 x 25 x 15 cm) on a metal mesh floor and allowed to acclimatize for 30 min. The filaments were presented, in ascending order of strength, perpendicular to the plantar surface with sufficient force to cause slight bending against the paw and held for 6 to 8 sec. Brisk withdrawal or paw flinching were considered as positive responses. The paw withdrawal mechanical threshold (PWMT) was determined by sequentially increasing and decreasing the stimulus strength (the "up-and-down" method), and the data were analyzed using the nonparametric method of Dixon, as described by Chaplan et al [14].

Thermal hyperalgesia [15] was assessed with the paw withdrawal thermal latency (PWTL) to radiant heat according to the protocol of Hargreaves et al [15]. Rats were placed in clear plastic cages on an elevated glass plate and allowed to acclimatize for 30 min before testing. A radiant thermal stimulator (BME410A, Institute of Biological Medicine, Academy of Medical Science, China) was focused onto the plantar surface of the hindpaw through the glass plate. The nociceptive endpoints in the radiant heat test were the characteristic lifting or licking of the hindpaw, and the time to the endpoint was considered the PWTL [16]. To avoid tissue damage, a cut-off time of 30 sec was used [17]. There were 5 trials per rat and 5 min intervals between trials. The mean PWTL was obtained from the final 3 stimuli [18].

Immunohistochemical staining.  Immunohistochemistry was used to detect nNOS and NR2B immunoreactivities in the spinal cord. Rats anesthetized with pentobarbital sodium (50 mg/kg, ip) were perfused through the ascending aorta with 0.9% NaCl, followed by freshly prepared 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS, pH 7.4). The lumbosacral spinal cords were carefully dissected out and stored in the same fixative for 3 hr (4°C). After fixation, spinal cord segments were cryoprotected in 20% sucrose with the same phosphate buffer and stored overnight at 4°C.

Transverse frozen sections (40 µm) were cut with a cryostat maintained at –28°C. Slices were placed in 0.3 % triton PBS for 30 min. Tissue sections were sequentially exposed to 10% goat serum for 10 min at room temperature and then to the primary antibody (NR2B, 1:1000; nNOS, 1:500) dilution at 4°C for 24 hr. Sections were washed twice with PBS and incubated in goat anti-rabbit serum (1:200) for 1 hr. This step was followed by three washes in PBS and staining using the ABC kit. The DAB chromogenic reaction was monitored carefully for about 5 min and PBS was used to stop the reaction in time.

Slices were fixed on microscope slides coated with gelatin. A computer-assisted image analysis system (Leica) was used to determine the number of positive neurons. Six random sections from each animal were observed at 400x magnification with an Olympus optical microscope equipped with an Olympus DP11 camera. For each rat, the mean number of cell counts in superficial lamina (I – III) of the spinal cord was calculated by averaging the number of stained cells from 6 sections.

Statistical analysis.  The data were expressed as means ± SD and analyzed by ANOVA, followed either by a multiple comparison test or by an unpaired t-test. Values of p <0.05 were considered statistically significant.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Acknowledgement
 References
 
Effect of intrathecal injection of PA on the paw withdrawal mechanical threshold.  Compared to the baseline before operation, the PWMT of all groups (except the sham group) showed down-regulation at 1 and 3 days after CCD (p <0.01) (Fig. 1Go). There were no significant differences between the CCD groups at these times. The PWMT of the PA 2.0 mg/kg group (but not the PA 0.5 mg/kg or PA 1.0 mg/kg groups) showed up-regulation compared to the ASCF group from days 5 to 15 postoperatively (p <0.05 (Fig. 1Go).


Figure 1
View larger version (18K):
[in this window]
[in a new window]

  		Fig. 1. Effect of prednisolone acetate (PA) on the paw withdrawal mechanical threshold with Von Frey filaments in CCD rats (n = 10 rats/group; mean ± SD; *p <0.05, **p <0.01 vs ACSF group; #p <0.05, ##p <0.01 vs baseline data).

 
Effect of intrathecal injection of PA on paw withdrawal thermal latency.  Intrathecal injection of ASCF did not affect the paw withdrawal thermal latency (PWMT) in rats of the sham group. The PWMT in rats of the other groups showed down-regulation compared to baseline at 1 and 3 days after CCD (p <0.01) (Fig. 2Go). Intrathecal injection of PA 2.0 mg/kg (but not PA 0.5 mg/kg or PA 1.0 mg/kg) prolonged the PWMT compared to the ASCF group from days 5 to 15 after the operation (p <0.01) (Fig. 2Go).


Figure 2
View larger version (18K):
[in this window]
[in a new window]

  		Fig. 2. Effect of prednisolone acetate (PA) on the paw withdrawal thermal latency in CCD rats (n = 10 rats/group; mean ± SD; *p <0.05, **p <0.01 vs ACSF group; #p <0.05 ##p <0.01 vs baseline data).

 
Effect of PA on nNOS immunohistochemical staining.  The effect of PA treatment on nNOS expression was determined in the superficial dorsal horn laminae I–III of the lumbar enlargement, which are areas that are involved in the transmission of nociceptive inputs and control of sympathetic outflow [19]. In agreement with previous reports, constitutive nNOS expression was weak to absent in the sham group. The expression of nNOS in the superficial dorsal horn of the ACSF, PA 0.5 mg/kg, and 1.0 mg/kg groups was increased significantly compared to the sham group (p <0.01) (Fig. 3Go). The expression of nNOS in the PA 2.0 mg/kg group was greatly decreased compared to the ACSF group, both on day 7 and day 14 postoperatively (p <0.05) (Fig. 3Go). Typical photomicrographs of the nNOS immunoreactive cells in the sham, ACSF, and PA 2.0 mg/kg groups are shown in Fig. 4Go.


Figure 3
View larger version (33K):
[in this window]
[in a new window]

  		Fig. 3. Effect of prednisolone acetate (PA) on the number of nNOS positive neurons in spinal dorsal horn ( n = 6 rats/ group; mean ± SD; *p <0.05, **p <0.01 vs sham group; #p <0.05 vs ACSF group).

 

Figure 4
Figure 4
Figure 4
View larger version (333K):
[in this window]
[in a new window]

  		Fig. 4. Typical photomicrographs (original magnification:100x) showing nNOS immunoreactive cells in the superficial dorsal horn (laminae I–III). In sham-operated rats only a few stained cells were observed (panel 1), whereas many nNOS immunopositive cells appeared in ACSF group rats (panel 2). The PA 2.0 mg/kg treated rats showed remarkably inhibited staining intensity compared to the ACSF group (panel 3).

 
Effect of PA on NR2B immunohistochemical staining.  The NR2B-positive neurons were greatly increased in the superficial dorsal horn of 3 groups (ACSF, PA 0.5 mg/kg, PA 1.0 mg/kg) compared to the sham group (p <0.01) both on days 7 and 14 postoperation; there were no significant differences among these 3 groups (Fig. 5Go). Compared to the ACSF group, the NR2B-positive neurons of the PA 2.0 mg/kg group were decreased on day 7 and day 14 postoperatively (p <0.01) (Fig. 5Go). Typical photomicrographs of NR2B immunoreactive cells in the sham, ACSF, and PA 2.0 mg/kg groups are shown in Fig. 6Go.


Figure 5
View larger version (30K):
[in this window]
[in a new window]

  		Fig. 5. Effect of prednisolone acetate (PA) on the number of NR2B positive neurons in spinal dorsal horn (n = 6 rats/ group; mean ± SD; **p <0.01 vs sham group; ##p <0.01 vs ACSF group).

 

Figure 6
Figure 6
Figure 6
View larger version (324K):
[in this window]
[in a new window]

  		Fig. 6. Typical photomicrographs (original magnification 100x) representing NR2B histochemistry staining of neurons in the dorsal horn (laminae I–III). Seven days after sham operation, a moderate basal staining intensity was obtained in sham operated rats (panel 1), which was substantially increased in ACSF group rats (panel 2), and PA 2.0 mg/kg remarkably inhibited the increased expression in the spinal cord (panel 3).

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Acknowledgement
 References
 
Peripheral nerve injury leads to central sensitisation, where increased excitability of neurons in the spinal dorsal horn leads to chronic hyperalgesia and allodynia. In this study we describe effects of PA on behavior and on NR2B and nNOS expression in the spinal dorsal horn lamina I–III of CCD rats.

In agreement with previous studies, the paw withdrawal mechanical threshold (PWMT) and paw withdrawal thermal latency (PWTL) of CCD rats with artificial cerebrospinal fluid (ACSF) treament were significantly lower than the sham group [13]. Our results show these behavioral changes can last a long time (15 days). Intrathecal injection of PA (2.0 mg/kg) every 3 days reversed the neuropathic pain behaviors. We found a virtual abolition of thermal hyperalgesia and marked attenuation of mechanical allodynia in the PA 2.0 mg/kg group, compared to the ACSF group. This did not happen in the PA 0.5 mg/kg or PA 1.0 mg/ kg groups. Thus the effect of prednisolone acetate is dependent on the dose given intrathecally.

For the expression of NR2B, low levels of NR2B immunoreactive neurons were found in spinal cord within laminae I–III of the sham-operated animals. However, a high number of NR2B immunoreactive neurons appeared in these laminae of rats with ACSF treament. As previous data show, the NR2B subunits are important candidates in the activation of NMDA receptors, which play a pivotal role in injury-induced sensitization in the spinal cord. Immunoblotting and immunohistochemical studies show an alteration in expression levels of NR2B in animals with established neuropathic pain [20].

Recent evidence suggests that NR2B protein shows a distribution associated both with small diameter fibres in laminae I and II, which are postulated to be of primary afferent origin [21], and post-synaptically on dorsal horn neurons [22]. This study shows that the expression of NR2B subtypes in the spinal dorsal horn changes radically over the time of neuropathic pain in CCD rats and that the increased expression is reversed by it injection of PA (2.0 mg/kg).

A close correlation between nNOS and neuropathic pain has been documented [23]. Some reports indicate that NO-producing neurons maintain and facilitate hyperalgesia [24]. In our studies, CCD also produced a unilateral increase in the level of nNOS positive neurons in the superficial layers within laminae I–III. Strong nociceptive input derived from spinal cord hemisection, root avulsion, hindpaw inflammation, and axotomy produces robust increases in NOS immunoreactivity. These stimuli caused at most a transient increase for a few hours, followed by a decrease persisting over many days [10]. However, in our study, the increased nNOS positive neurons in superficial layers within laminae I–III of the ACSF group at 7 and 14 days after CCD may be the result of de novo synthesis of the enzyme and its transport from the dorsal root ganglia to the spinal cord, although up-regulation of the enzyme activity in local interneurons is also possible [25].

Our data demonstrate that PA exerts an inhibitory effect on the number of NR2B and nNOS positive neurons in lamina I–III, elevated as a consequence of CCD. In this context, both of these molecules have been implicated in nociceptive transmission, because their inhibition resulted in a diminished response to pain. For the decrease of NR2B positive neurons, in molecular terms, GC action upon NR2B may be related to steroid anti-inflammatory and immunosuppressive effects, mainly achieved by transcriptional interference.

As to nNOS, both natural and synthetic GC exert a negative regulation of this enzyme in brain and spinal cord motoneurons [26,27]. Dexamethasone (DEX) can also reduce apoptosis in contused spinal cord [28]. The inhibition was also found in macrophages in an in vitro study [29]. Interestingly, our data show that both NR2B and nNOS are inhibited by PA. Reuss and Reuss [30] reported that the NMDA receptor activates NOS post-synaptically and that NOS produces NO release to pre-synaptically up-regulate the function of the NMDA receptor. Thus the NMDA receptor and NOS comprise a local circuit that amplifies the signal of nociceptive transmission. If sustained production of these factors after CCD is required for maintenance of experimentally-produced hyperalgesia, and if their lesion-induced increase is likely to cause persistence of pain, blockade of this circuit by GC treatment would likely reduce pain excitatory neurotransmission at the spinal cord level. In clinical studies, GC has a good effect in curing intervertebral disk hernia through extension of inflammatory reaction and hydropsia ambient to the nerve root. Recent data show that epidural injection of PA can relieve the pain of patients after a spinal operation. All of these findings indicate GC has analgesic effects at the spinal level.

Our results indicate that CCD can induce long-lasting NR2B and nNOS up-regulation in the spinal dorsal horn. This up-regulation may contribute to nociceptor activity-induced spinal plasticity and development of central sensitization and persistent pain. Furthermore, intrathecal injection of PA 2.0 mg/kg remarkably inhibited CCD-induced mechanical allodynia and thermal hyperalgesia and inhibited the increases of NR2B and nNOS expression in the spinal cord. These results suggest that activation of the NMDA-NOS pathway contributes to the development of neuropathic pain induced by CCD. The analgesia of intrathecal administration of PA may be mediated by the interruption of this pathway.


   Acknowledgement
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Acknowledgement
References
 
This research was supported by Grant 02KJB320012 from the Department of Education Foundation of Jiangsu Province, China.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Acknowledgement
 References
 

  1. Bartholdi D, Schwab ME. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res 1995;672:177–186.[Medline]
  2. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. Corticosteroids are transcriptional regulators of acute inflammation. Trans Assoc Am Phys 1992;105:25–35.[Medline]
  3. Brandoli C, Shi B, Pflug B, Andrews P, Wrathall JR, Mochetti II. Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cord. Mol Brain Res 2001;2001:61–70.
  4. Kohama I, Ishikawa K, Kocsis JD. Synaptic reorganization in the substantia gelatinosa after peripheral nerve neuroma formation: aberrant innervation of lamina II neurons by a-beta afferents. J Neurosci 2000;20:1538–1549.[Abstract/Free Full Text]
  5. Sotgiu ML, Biella G. Differential effects of MK-801, a N-methyl-D-aspartate non-competitive antagonist, on the dorsal horn neuron hyperactivity and hyperexcitability in neuropathic rats. Neurosci Lett 2000;283:153–156.[Medline]
  6. Garry EM, Moss A, Delaney A, O’Neill F, Blakemore J, Bowen J, Husi H, Mitchell R, Grant SG, Fleetwood-Walker SM. Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice. Curr Biol 2003;13:321–328.[Medline]
  7. Suzuki R, Matthews EA, Dickenson AH. Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurons in a rat model of mononeuropathy. Pain 2001;91:101–109.[Medline]
  8. Laurido C, Pelissier T, Perez H, Flores F, Hernandez A. Effect of ketamine on spinal cord nociceptive transmission in normal and monoarthritic rats. Neuroreport 2001;12:1551–1554.[Medline]
  9. Guo W, Zou S, Guan Y, Ikeda T, Tal M, Dubner R, Ren K. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J Neurosci 2002;22:6208–6217.[Abstract/Free Full Text]
  10. Callsen-Cencic P, Hoheisel U, Kaske A, Mense S, Tenschert S. The controversy about spinal neuronal nitric oxide synthase: under which conditions is it up- or down-regulated? Tissue Res 1999;295:183–194.
  11. Lopez-Figueroa MO, Itoi K, Watson SJ. Regulation of nitric oxide synthase messenger RNA expression in the rat hippocampus by glucocorticoids. Neuroscience 1998; 87:439–446.[Medline]
  12. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976;17:1031–1036[Medline]
  13. Song XJ, Hu SJ, Greenquist KW, Zhang JM, LaMotte RH. Mechanical and thermal hyperalgesia and ectopic neuronal discharge after chronic compression of dorsal root ganglia. J Neurophysiol 1999;82:3347–3358.[Abstract/Free Full Text]
  14. Chaplan SR, Bach FW. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Meth 1994;53: 55–63.[Medline]
  15. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77–88.[Medline]
  16. Chen J, Luo C, Li H, Chen H. Primary hyperalgesia to mechanical and heat stimuli following subcutaneous bee venom injection into the plantar surface of hindpaw in the conscious rat: a comparative study with the formalin test. Pain 1999;83:67–76.[Medline]
  17. Ji GC, Ma F, Zhang YQ, Wu GC. Thermal hyperalgesic effects induced by intracerebroventricular injection of interleukin-1beta in rats. Sheng Li Xue Bao 2002;54:325–328.[Medline]
  18. Sun YY, Luo C, Li Z, Chen J. Differential actions of intrathecal nociceptin on persistent spontaneous nociception, hyperalgesia and inflammation produced by subcutaneous bee venom injection in conscious rats. Sheng Li Xue Bao 2004;56:321–327.[Medline]
  19. Furst S. Transmitters involved in antinociception in the spinal cord. Brain Res Bull 1999;48:129–141.[Medline]
  20. Karlsson U, Sjodin J, Angeby-Moller K, Johansson S, Wikstrom L, Nasstrom J. Glutamate-induced currents reveal three functionally distinct NMDA receptor populations in rat dorsal horn–effects of peripheral nerve lesion and inflammation. Neuroscience 2002;112:861–868.[Medline]
  21. Ma QP, Hargreaves RJ. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience 2000;101:699–707.[Medline]
  22. Momiyama A. Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn neurones of the adult rat spinal cord. J Physiol 2000;523:621–628.[Abstract/Free Full Text]
  23. Cizkova D, Lukacova N, Marsala M, Marsala J. Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn. Brain Res Bull 2002;58:161–171.[Medline]
  24. Traub RJ, Solodkin A, Meller ST, Gebhart GF. Spinal cord NADPH-diaphorase histochemical staining but not nitric oxide synthase immunoreactivity increases following carrageenan-produced hindpaw inflammation in the rat. Brain Res 1994;668:204–210.[Medline]
  25. Ruda MA, Besse D, Inagaki S, Deleon M, Ren K. Nitric oxide expression and regulation in the dorsal root ganglion and spinal cord. Ann NY Acad Sci 1994;738: 181–190.[Medline]
  26. Gonzalez D, Gonzalez SL, Lima AE, Wilkin G, De Nicola AF. The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis. Neurochem Res 1999;24:1–8.[Medline]
  27. Schwarz PM, Gierten B, Boissel JP, Forstermann U. Expressional down-regulation of neuronal-type nitric oxide synthase I by glucocorticoids in N1E-115 neuroblastoma cells. Mol Pharmacol 1998;54:258–263.[Abstract/Free Full Text]
  28. Brandoli C, Shi B, Pflug B, Andrews P, Wrathall JR, Mochetti II, Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cord. Mol Brain Res 2001;19:61–70.
  29. Cato AC, Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 1996; 18:371–378.[Medline]
  30. Reuss MH, Reuss S. Nitric oxide synthase neurons in the rodent spinal cord: distribution, relation to substance P fibers, and effects of dorsal rhizotomy. Chem Neuroanat 2001;21:181–196.



This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
X. Gu, F. Mei, Y. Liu, R. Zhang, J. Zhang, and Z. Ma
Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyl-D-Aspartic Acid
Anesth. Analg., August 1, 2011; 113(2): 405 - 411.
[Abstract] [Full Text] [PDF]

Home page
 Ann Clin Lab SciHome page
Z.-L. Ma, W. Zhu, W. Zhang, and X.-p. Gu
Effect of the Synaptic Scaffolding Protein Homer1a on Chronic Compression of Dorsal Root Ganglion
Ann. Clin. Lab. Sci., January 1, 2009; 39(1): 71 - 75.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
E. Niederberger and G. Geisslinger
The IKK-NF-{kappa}B pathway: a source for novel molecular drug targets in pain therapy?
FASEB J, October 1, 2008; 22(10): 3432 - 3442.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, Z.-L.
Right arrow Articles by Zeng, Y.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, Z.-L.
Right arrow Articles by Zeng, Y.-M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS